Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SeegnalTSXV:SEGN 2 Gross Margin % is -4.72% as of Mar. 2026. GuruFocus rates TSXV:SEGN with a GF Score™ of 2/100. The stock has 3 warning signs investors should review. Among 627 Healthcare Providers & Services companies, Seegnal ranks worse than 98.56% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Seegnal's Gross Profit for the
three
months ended in Mar. 2026 was C$-0.02 Mil. Seegnal's Revenue for the
three
months ended in Mar. 2026 was C$0.49 Mil. Therefore, Seegnal's Gross Margin % for the quarter that ended in Mar. 2026 was -4.72%.
The historical rank and industry rank for Seegnal's Gross Margin % or its related term are showing as below:
TSXV:SEGN'
s Gross Margin % Range Over the Past 10 Years
Min: 0.17 Med: 1.5 Max: 2.37
Current: 0.17
During the past 2 years, the highestGross Margin % of Seegnal was 2.37%. The lowest was 0.17%. And the median was 1.50%.
TSXV:SEGN's Gross Margin % is ranked worse than 98.56% of 627
companies
in the Healthcare Providers & Services industry
Industry Median: 40.06
vs TSXV:SEGN: 0.17
Seegnal had a gross margin of -4.72% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Seegnal was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Seegnal had a gross margin of -4.72% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Seegnal Gross Margin % Related Terms
Seegnal Gross Margin % Historical Data
* Premium members only.
The historical data trend for Seegnal's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:SEGN vs VEEV, BTSG, HQY: Gross Margin % Comparison
For the Health Information Services subindustry, Seegnal's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Seegnal Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Seegnal's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Seegnal's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Seegnal (TSXV:SEGN) has a Gross Margin % of -4.72% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Seegnal and its competitors. Over the past decade, Seegnal's Gross Margin % has ranged from 0.17 to 2.37. According to the industry distribution chart, Seegnal ranks #618 out of 627 companies in the Healthcare Providers & Services industry, placing it in the top 98.6%.
Is Seegnal's Gross Margin % too high?
Seegnal's current Gross Margin % is -4.72%. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 2.37. Based on the distribution chart, Seegnal ranks #618 out of 627 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Seegnal has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does Seegnal's Gross Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Seegnal ranks #618 out of 627 companies for Gross Margin %. This places Seegnal in the lower half of its industry. The industry median Gross Margin % is 40.06. Historically, Seegnal's own Gross Margin % has ranged from 0.17 to 2.37 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.06, based on 627 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Seegnal and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Seegnal's current Gross Margin % is -4.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seegnal stock overvalued right now?
Seegnal (TSXV:SEGN) has a current Gross Margin % of -4.72%. The current Gross Margin % is -4.72%. Seegnal's overall GF Score™ is 2/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Seegnal (TSXV:SEGN), the current Gross Margin % is -4.72% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Seegnal Inc is a med-tech software as a service (SaaS) company focused on the development and commercialization of a patient-centric clinical decision support system designed to mitigate drug-related problems at the point of care. It provides AI-enhanced clinical decision support software that helps healthcare providers prescribe medications safely and efficiently at the point of care (the Seegnal Platform). It analyzes patient-specific clinical data and medication regimens in real time to identify potential drug-related risks, including drug-drug interactions, contraindications, and adverse drug events. By integrating with electronic medical record systems, its platform supports clinicians in improving patient safety, optimizing medication use, and reducing healthcare costs.
2GF Score
Get the complete analysis for TSXV:SEGN
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:SEGN has been successfully added to your 
